Cardio Diagnostics (CDIO) vs Q/C Technologies (QCLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cardio Diagnostics is the larger company by market cap ($4.7 million vs $2.4 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDIO | QCLS |
|---|---|---|
| Share price | $1.60 | $0.2784 |
| Market cap | $4.74M | $2.40M |
| 1-day change | -3.03% | -6.01% |
| P/E ratio (TTM) | — | 0.06 |
| EPS (TTM) | $-2.52 | $4.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $14.82K | — |
| Revenue growth (YoY) | -57.51% | — |
| Net income (latest FY) | $-6.50M | $-11.63M |
| Operating margin | -43737.46% | — |
| Net margin | -43832.49% | — |
| 52-week high | $7.91 | $8.17 |
| 52-week low | $0.97 | $0.275 |
| Distance from 52-week high | -79.77% | -96.59% |
| Average volume | 26.91K | 5.05M |
| Shares outstanding | 2.96M | 8.62M |
| Employees | 15 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cardio Diagnostics
CDIO stock →Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 15 employees
About Q/C Technologies
QCLS stock →Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 3 employees
CDIO vs QCLS FAQ
Which is bigger, Cardio Diagnostics or Q/C Technologies?
Cardio Diagnostics (CDIO) is larger, with a market capitalization of $4.74M compared with $2.40M for Q/C Technologies (QCLS).
Are Cardio Diagnostics and Q/C Technologies in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.